DNA Polymerase Delta 1 Catalytic Subunit (POLD1) as a Prognostic Factor in Clear Cell Renal Cell Carcinoma Patients | In Vivo
Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.,Scientific Reports - X-MOL
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers | JCO Precision Oncology
POLE and POLD1 pathogenic variants in the proofreading domain in papillary thyroid cancer in: Endocrine Connections Volume 9 Issue 9 (2020)
JCI - Polymerase δ deficiency causes syndromic immunodeficiency with replicative stress
POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies - ScienceDirect
Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patient
ICARE Social Media Post March 2020Colon Cancer and Polyp Risks – Inherited Cancer Registry (ICARE)
Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomas - ScienceDirect
MODAPLEX POLE/POLD1 Mutation Analysis Kit | MODAPLEX
Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
The structure of POLE and POLD1 demonstrating the position of key... | Download Scientific Diagram
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes | Oncogene
POLD1 - Wikipedia
New recommendations for the classification of variants in the POLE and POLD1 genes to improve diagnostic accuracy in hereditary cancer – IDIBELL
Correlation between POLE/POLD1 mutation and TMB and MSI. The TMB of... | Download Scientific Diagram
Constitutional POLE variants causing a phenotype reminiscent of constitutional mismatch repair deficiency - Sehested - 2022 - Human Mutation - Wiley Online Library
POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
![PDF] Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c346f13df0db26876466b417c19c4b44c65bd545/11-Figure5-1.png "PDF] Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL). | Semantic Scholar")
PDF] Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL). | Semantic Scholar
POLE/POLD1 Mutations and Outcomes With Immune Checkpoint Inhibitor Therapy - The ASCO Post
JAMA Oncology on X: "Analysis of results from database of 47,721 pts w/different cancers shows variable prevalence of DNA polymerase epsilon ( POLE) & delta 1 (POLD1) mut'ns that correlates w/overall survival in
Characterization of Known and Novel POLE and POLD1 Drivers (A) Examples... | Download Scientific Diagram
The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management | Familial Cancer
Elevated somatic mutation burdens in normal human cells due to defective DNA polymerases | bioRxiv
Cancers | Free Full-Text | Polymerase Epsilon-Associated Ultramutagenesis in Cancer
Cancers | Free Full-Text | Prospects of POLD1 in Human Cancers: A Review
